Yahoo Web Search

  1. Celgene said on Monday it agreed to buy rest of Juno Therapeutics for about $9 billion in cash to gain access to Juno's pipeline of CAR-T cancer drugs. Celgene already owns 9.7 percent in Juno ...

  2. BOULDER, Colo., Jan. 22, 2018 /PRNewswire/ -- Front Range Biosciences, a leading agricultural biotechnology company specializing in tissue culture propagation of high value crops, is ...

  3. French drugmaker Sanofi is close to acquiring biotechnology company Bioverativ for $105 a share, valuing the maker of hemophilia drugs at about $11.4 billion, according to a person familiar ...

  4. The Summit, New Jersey-based biotechnology company will pay $87 a share in cash, according to a statement Monday. It trails deals by Gilead Sciences Inc. and Takeda Pharmaceutical Co.

  5. SEATTLE, Jan. 22, 2018 /PRNewswire/ -- Kineta Immuno-oncology, LLC, a biotechnology company focused on developing disruptive technologies to turn cold tumor...

  6. biotechnology firm Medivation Inc. Sanofi’s offer for the company caused other bidders to pile in, and Medivation signed a deal to sell itself to Pfizer Inc. for $14 billion. Sanofi also ...

  7. The largest exchange-traded fund to track the biotechnology sector rallied on Monday, supported by a pair of multibillion-dollar deals. The iShares Nasdaq Biotechnology ETF IBB ...

  8. British biotechnology firm Abcam Plc said on Monday it signed a deal with Roche Holding AG to get rights to a portfolio of the Swiss drugmaker's research products in its life science ...

  9. The largest exchange-traded funds to track the biotechnology sector rallied on Monday, surging after a pair of multibillion-dollar deals were announced. The SPDR S&P Biotech ETF XBI, ...

  10. SAN MATEO, Calif., Jan. 22, 2018 /PRNewswire/ -- Medeor Therapeutics, Inc., a clinical-stage biotechnology company dedicated to the discovery, development and commercialization of personalized ...

  1. 12345700 results